Multimodal treatment for resectable epithelial type malignant pleural mesothelioma

Ichiro Yoshino, Masafumi Yamaguchi, Tatsuro Okamoto, Chie Ushijima, Yasuro Fukuyama, Yukito Ichinose, Oshihiko Maehara

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background: Malignant pleural mesothelioma is a rare malignancy. The outcome remains poor despite complete surgical resection. Patients and methods: Eleven patients with histologicaly proven epithelial type malignant pleural mesothelioma undergoing extrapleural pneumonectomy with systemic chemotherapy and/or radiotherapy before and after surgical resection were retrospectively reviewed. Results: Ten out of 11 patients underwent complete surgical resection, of these 7 patients had stage I disease. Of these 7 patients, 5 are alive without any recurrence, a 2-year survival rate of 80% was observed in this group. There was no operative mortality or morbidity. Conclusion: Extrapleural pneumonectomy with perioperative adjuvant treatment is safe and effective procedure for epithelial type malignant pleural mesothelioma.

Original languageEnglish
Article number11
JournalWorld Journal of Surgical Oncology
Volume2
DOIs
Publication statusPublished - May 5 2004

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'Multimodal treatment for resectable epithelial type malignant pleural mesothelioma'. Together they form a unique fingerprint.

  • Cite this

    Yoshino, I., Yamaguchi, M., Okamoto, T., Ushijima, C., Fukuyama, Y., Ichinose, Y., & Maehara, O. (2004). Multimodal treatment for resectable epithelial type malignant pleural mesothelioma. World Journal of Surgical Oncology, 2, [11]. https://doi.org/10.1186/1477-7819-2-11